Financials

  • Market Capitalization 5.42 M
  • Employee 6
  • Founded 2009
  • CEO N/A
  • Website www.kalarx.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2MVT8
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.17
ratio cours/chiffre d'affaires
—

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4818
AIM
AIM ImmunoTech Inc. Common Stock
0.18 USD0.00%-5.26%-18.18%-92.97%5.48 M USD
4820
CDIO
Cardio Diagnostics Holdings Inc. - Common stock
1.78 USD-6.81%-13.59%-12.32%-32.19%5.27 M USD
4823
LEXX
Lexaria Bioscience Corp. - Common Stock
3.27 USD-1.51%+18.05%-17.84%+293.98%5.40 M USD
4833
PULM
Pulmatrix, Inc. - Common Stock
1.43 USD-2.05%-3.38%-1.38%-71.34%5.22 M USD

Nouvelles